PDXモデルの北米市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】North America PDX Models Market : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810493)・商品コード:DBMR810493
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年7月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:北米
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥361,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、PDXモデルの北米市場について調査・分析し、PDXモデルの北米市場動向、市場予測、セグメント別分析、PDXモデル市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

North America PDX models market is expected to hold the leading market share in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for North America PDX models market are listed below:

• Crown Bioscience Inc.
• The Jackson Laboratory
• Champion Oncology, Inc.
• Charles River
• Oncodesign
• Wuxi AppTec
• Horizon Discovery Group plc
• Pharmatest Services
• Hera Biolabs
• EPO Berlin-Buch GmbH
• Xentech
• Urolead
• Creative Animodel
• EUROPDX
• MI Bioresearch Inc
• Aragen Bioscience

The market is further segmented into:
• Type
• Tumor Type
• Application
• End User

The North America PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share by 2025.
The North America PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
The North America PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
The North America PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
Based on geography, the market is segmented into:
• U.S.
• Canada
• Mexico
Covered in this report
The report covers the present scenario and the growth prospects of the North America PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1 Introduction 10
1.1 Objectives Of The Study 10
1.2 Market Definition 10
1.3 Overview Of North America Pdx Models Market 10
1.4 Currency And Pricing 11
1.5 Limitation 11
1.6 Markets Coveredss 11
2 Market Segmentation 13
2.1 Markets Covered 13
2.2 Geographic Scope 14
2.3 Years Considered For The Study 14
2.4 Currency And Pricing 15
2.5 Research Methodology 16
2.6 Primary Interviews With Key Opinion Leaders 19
2.7 Secondary Sources 20
2.8 Assumptions 20
3 Market Overview 21
3.1 Drivers 23
3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 23
3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 25
3.1.3 Rising Need For Personalized Medicine 26
3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 26
3.2 Restraints 27
3.2.1 High Cost Of Pdx Models 27
3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 27
3.3 Opprtunities 28
3.3.1 Increasing Demand For Humanized Pdx Models 28
3.4 Challenges 29
3.4.1 Limitations Of Pdx Models 29
4 Executive Summary 30
5 Premium Insights 32
6 North America Pdx Models Market, By Type 35
6.1 Overview 36
6.2 Mice Models 38
6.3 Rat Models 39
7 North America Pdx Models Market, By Tumor Type 40
7.1 Overview 41
7.2 Gastrointestinal Tumor Models 43
7.3 Gynecological Tumor Models 44
7.4 Respiratory Tumor Models 45
7.5 Urological Tumor Models 46
7.6 Hematological Tumor Models 47
7.7 Others 48
8 North America Pdx Models Market, By Application 49
8.1 Overview 50
8.2 Preclinical Drug Development And Oncology Research 52
8.3 Biomarker Analysis 53
9 North America Pdx Models Market, By End User 54
9.1 Overview 55
9.2 Contract Research Organizations 57
9.3 Pharmaceutical And Biotechnology Companies 58
9.4 Academic And Research Institutions 59
10 North America Pdx Models Market, By Geography 60
10.1 North America 60
10.1.1 U.S. 69
10.1.2 Canada 71
10.1.3 Mexico 73
11 North America Pdx Models Market, Company Landscape 75
11.1 Company Share Analysis: North America 75
12 Company Profiles 76
12.1 Charles River 76
12.1.1 Company Overview 76
12.1.2 Revenue Analysis 76
12.1.3 Company Share Analysis 77
12.1.4 Product Portfolio 77
12.1.5 Recent Developments 77
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 78
12.2.1 Company Overview 78
12.2.2 Geographic Presence 78
12.2.3 Company Share Analysis 79
12.2.4 Product Portfolio 79
12.2.5 Recent Developments 80
12.3 Champion Oncology, Inc 81
12.3.1 Company Overview 81
12.3.2 Revenue Analysis 81
12.3.3 Company Share Analysis 82
12.3.4 Product Portfolio 82
12.3.5 Recent Developments 82
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 83
12.4.1 Company Overview 83
12.4.2 Product Portfolio 83
12.4.3 Recent Developments 83
12.5 Creative Animodel 84
12.5.1 Company Overview 84
12.5.2 Product Portfolio 84
12.5.3 Recent Developments 84
12.6 Epo Berlin-Buch Gmbh 85
12.6.1 Company Overview 85
12.6.2 Product Portfolio 85
12.6.3 Recent Developments 85
12.7 Europdx 86
12.7.1 Company Overview 86
12.7.2 Geographical Presence 86
12.7.3 Product Portfolio 87
12.7.4 Recent Developments 87
12.8 Hera Biolabs 88
12.8.1 Company Overview 88
12.8.2 Product Portfolio 88
12.8.3 Recent Developments 88
12.9 Horizon Discovery Group Plc 89
12.9.1 Company Overview 89
12.9.2 Revenue Analysis 89
12.9.3 Product Portfolio 90
12.9.4 Recent Developments 90
12.10 Mi Bioresearch Inc 91
12.10.1 Company Overview 91
12.10.2 Product Portfolio 91
12.10.3 Recent Developments 91
12.11 Oncodesign 92
12.11.1 Company Overview 92
12.11.2 Revenue Analysis 92
12.11.3 Product Portfolio 93
12.11.4 Recent Developments 93
12.12 Pharmatest Services Ltd 94
12.12.1 Company Overview 94
12.12.2 Geographic Presence 94
12.12.3 Product Portfolio 95
12.12.4 Recent Developments 95
12.13 The Jackson Laboratory 96
12.13.1 Company Overview 96
12.13.2 Revenue Analysis 96
12.13.3 Product Portfolio 97
12.13.4 Recent Developments 97
12.14 Urolead 98
12.14.1 Company Overview 98
12.14.2 Product Portfolio 98
12.14.3 Recent Developments 98
12.15 Wuxi Apptec 99
12.15.1 Company Overview 99
12.15.2 Geographic Presence 99
12.15.3 Product Portfolio 100
12.15.4 Recent Developments 100
12.16 Xentech 101
12.16.1 Company Overview 101
12.16.2 Product Portfolio 101
12.16.3 Recent Developments 101
13 Related Reports 102

List Of Tables
Uu
Table 1 North America Pdx Models Market, By Type, 2016– 2025, (Usd Million) 37
Table 2 North America Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 38
Table 3 North America Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 39
Table 4 North America Pdx Models Market, By Tumor Type, 2016– 2025 (Usd Million) 42
Table 5 North America Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million) 43
Table 6 North America Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million) 44
Table 7 North America Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million) 45
Table 8 North America Urological Tumor Models Market, By Region, 2016-2025, (Usd Million) 46
Table 9 North America Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million) 47
Table 10 North America Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million) 48
Table 11 North America Pdx Models Market, By Application, 2016– 2025 (Usd Million) 51
Table 12 North America Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million) 52
Table 13 North America Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million) 53
Table 14 North America Pdx Models Market, By End User, 2016– 2025, (Usd Million) 56
Table 15 North America Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million) 57
Table 16 North America Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million) 58
Table 17 North America Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million) 59
Table 18 North America Pdx Models Market, By Country, 2016 – 2025, (Usd Million) 66
Table 19 North America Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 66
Table 20 North America Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 67
Table 21 North America Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 67
Table 22 North America Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 68
Table 23 U.S. Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 69
Table 24 U.S. Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 69
Table 25 U.S. Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 70
Table 26 U.S. Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 70
Table 27 Canada Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 71
Table 28 Canada Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 71
Table 29 Canada Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 72
Table 30 Canada Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 72
Table 31 Mexico Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 73
Table 32 Mexico Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 73
Table 33 Mexico Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 74
Table 34 Mexico Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 74




【レポートのキーワード】

PDXモデル

★調査レポート[PDXモデルの北米市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810493)販売に関する免責事項を必ずご確認ください。
★調査レポート[PDXモデルの北米市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆